N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride

C48H55ClF4N8O7S2 — CID 159026916

IUPACN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride
SMILESCc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCN(C3CC(O)C3)CC2)c1.Cc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCNCC2)c1.Cl
InChIInChI=1S/C26H30F2N4O4S.C22H24F2N4O3S.ClH/c1-17-3-2-4-20(13-17)32(37(34,35)23-9-11-31(12-10-23)21-14-22(33)15-21)16-18-5-7-19(8-6-18)25-29-30-26(36-25)24(27)28;1-15-3-2-4-18(13-15)28(32(29,30)19-9-11-25-12-10-19)14-16-5-7-17(8-6-16)21-26-27-22(31-21)20(23)24;/h2-8,13,21-24,33H,9-12,14-16H2,1H3;2-8,13,19-20,25H,9-12,14H2,1H3;1H
InChIKeyFCQNVMDMVVZXNR-UHFFFAOYSA-N
MW1031.60 g/mol
LogP8.80
Rot. Bonds15

About N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride

N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride (PubChem CID 159026916) has the molecular formula C48H55ClF4N8O7S2 and a molecular weight of 1031.60 g/mol. Its IUPAC name is N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride.

Molecular Properties

Compound NameN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride
PubChem CID159026916
Molecular FormulaC48H55ClF4N8O7S2
Molecular Weight1031.60 g/mol
Exact Mass1030.33
IUPAC NameN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride
SMILESCc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCN(C3CC(O)C3)CC2)c1.Cc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCNCC2)c1.Cl
InChIInChI=1S/C26H30F2N4O4S.C22H24F2N4O3S.ClH/c1-17-3-2-4-20(13-17)32(37(34,35)23-9-11-31(12-10-23)21-14-22(33)15-21)16-18-5-7-19(8-6-18)25-29-30-26(36-25)24(27)28;1-15-3-2-4-18(13-15)28(32(29,30)19-9-11-25-12-10-19)14-16-5-7-17(8-6-16)21-26-27-22(31-21)20(23)24;/h2-8,13,21-24,33H,9-12,14-16H2,1H3;2-8,13,19-20,25H,9-12,14H2,1H3;1H
InChIKeyFCQNVMDMVVZXNR-UHFFFAOYSA-N
XLogP8.80
TPSA188.10 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds15
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001031.60
LogP ≤ 58.80
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride?
The IUPAC name of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride (CID 159026916) is N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride.
What is the SMILES notation for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride?
The canonical SMILES for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride is Cc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCN(C3CC(O)C3)CC2)c1.Cc1cccc(N(Cc2ccc(-c3nnc(C(F)F)o3)cc2)S(=O)(=O)C2CCNCC2)c1.Cl.
What is the InChIKey of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride?
The InChIKey is FCQNVMDMVVZXNR-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30F2N4O4S.C22H24F2N4O3S.ClH/c1-17-3-2-4-20(13-17)32(37(34,35)23-9-11-31(12-10-23)21-14-22(33)15-21)16-18-5-7-19(8-6-18)25-29-30-26(36-25)24(27)28;1-15-3-2-4-18(13-15)28(32(29,30)19-9-11-25-12-10-19)14-16-5-7-17(8-6-16)21-26-27-22(31-21)20(23)24;/h2-8,13,21-24,33H,9-12,14-16H2,1H3;2-8,13,19-20,25H,9-12,14H2,1H3;1H.
What are the key properties of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride?
N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride has a molecular weight of 1031.60 g/mol, XLogP of 8.80, 15 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-1-(3-hydroxycyclobutyl)-N-(3-methylphenyl)piperidine-4-sulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(3-methylphenyl)piperidine-4-sulfonamide;hydrochloride is sourced from PubChem (CID 159026916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).